Does Brahmi, Ashwagandha, or Shankhpushpi Actually Improve Memory and Cognition? What the Evidence Shows

What exactly are Medhya Rasayanas, and where do these herbs fit?

Medhya Rasayana is defined in Ayurvedic texts as a category of herbs and formulations specifically prescribed to enhance intellect (medha), memory (smriti), and mental clarity. The word "medhya" derives from the Sanskrit root for intellect, and "rasayana" refers to a rejuvenating tonic. Brahmi, Ashwagandha, Shankhpushpi, and Guduchi are the four herbs most commonly classified as Medhya Rasayanas in classical texts such as Charaka Samhita.

This classification matters because it tells you how these herbs have been used for millennia — not as acute stimulants like caffeine, but as slow-acting tonics meant to be taken consistently over weeks or months. Modern clinical research has broadly confirmed this timeline: the cognitive benefits of Brahmi, for instance, typically emerge only after 8–12 weeks of daily supplementation, which aligns with the Ayurvedic instruction to take Rasayanas as a sustained course rather than a single dose.

Hindustan Times reports that Ayurvedic experts increasingly frame these herbs within a broader cognitive wellness routine that includes sleep, diet, and stress management — not as standalone pills.

How strong is the evidence for Brahmi improving memory?

Brahmi is defined in modern pharmacology as a standardised extract of Bacopa monnieri, a creeping herb native to wetlands across the Indian subcontinent. Its primary bioactive compounds are bacosides A and B, triterpenoid saponins believed to support synaptic transmission and protect neurons from oxidative damage.

The clinical evidence for Brahmi is the most solid of the three herbs discussed here. A 2017 study published in PMC (PubMed Central) examined the neurocognitive effects of Brahmi and found measurable improvements in memory acquisition, retention, and recall in human subjects. The study noted that Brahmi's effects on the cholinergic system — the neurotransmitter pathway central to memory formation — are a plausible mechanism for these benefits.

Key findings from the broader Brahmi research literature:

Multiple double-blind, placebo-controlled RCTs in healthy adults show statistically significant improvements in delayed word recall, visual memory, and learning rate after 8–12 weeks of supplementation at 300–450 mg/day of a standardised extract.
A meta-analysis of nine RCTs found that Bacopa monnieri significantly improved speed of visual information processing, learning rate, and memory consolidation, with the strongest effects seen in older adults.
Brahmi also demonstrates consistent anxiolytic (anti-anxiety) effects, which may indirectly support cognition by reducing the cortisol-mediated memory impairment that accompanies chronic stress.
The herb appears to inhibit acetylcholinesterase — the enzyme that breaks down acetylcholine — which is the same mechanism targeted by pharmaceutical drugs used in Alzheimer's disease treatment, though Brahmi's effect is far milder.

The primary caveat is that most positive RCTs use standardised extracts with a defined bacoside content (typically 20–55%), whereas many Indian market products are raw powder or unstandardised extracts with unpredictable potency. Gastrointestinal side effects — nausea, cramping, increased stool frequency — are the most commonly reported adverse effects, particularly at doses above 450 mg/day.

For those also interested in other evidence-based Ayurvedic supplements, our guide to Arjuna for heart health applies a similar evidence-grading framework to cardiac herbs.

Does Ashwagandha actually help with memory and focus, or just stress?

Ashwagandha (Withania somnifera) is defined in Ayurveda as an adaptogen — a substance that helps the body resist physical and psychological stress without causing stimulation or sedation. Its primary bioactive compounds are withanolides, a class of steroidal lactones concentrated in the root.

The cognitive evidence for Ashwagandha is meaningful but more nuanced than Brahmi's. Most of the strongest RCTs show cognitive benefits that are secondary to stress reduction rather than direct nootropic effects. That distinction matters for buyers: if your memory problems stem from chronic stress, poor sleep, or anxiety, Ashwagandha may be highly relevant. If you want to enhance baseline memory in a low-stress, well-rested individual, the evidence is thinner.

A 2021 study published in PMC specifically examined Ashwagandha root extract for cognitive function and found statistically significant improvements in immediate and general memory, executive function, sustained attention, and information-processing speed in healthy adults over an 8-week period. The dose used was 300 mg of a standardised root extract (KSM-66 or equivalent), taken twice daily. The study also measured cortisol levels and found a significant reduction, suggesting that the cognitive improvements were at least partly mediated by stress hormone normalisation.

Additional evidence points:

Ashwagandha consistently reduces serum cortisol levels in stressed adults, which is directly relevant to cognition because elevated cortisol damages the hippocampus — the brain region most critical for memory formation.
Several RCTs show improvements in reaction time and psychomotor speed, cognitive domains not typically addressed by Brahmi.
Ashwagandha has demonstrated neuroprotective effects in preclinical models, including inhibition of beta-amyloid plaque formation relevant to Alzheimer's disease, though no human trials have confirmed disease-modifying effects.
The herb is also used to support testosterone and thyroid function, which can indirectly affect cognitive clarity, particularly in men over 40.

Safety considerations are important. Ashwagandha is generally well-tolerated at 300–600 mg/day of a standardised root extract, but rare cases of liver injury have been reported at high doses or with prolonged use. People with thyroid conditions — particularly hyperthyroidism — should consult a physician before use, as Ashwagandha can stimulate thyroid hormone production. It also has mild sedative properties that may be beneficial for sleep but can cause drowsiness if taken in the morning.

What does the science actually say about Shankhpushpi?

Shankhpushpi (Convolvulus pluricaulis) is defined in Ayurvedic pharmacology as a nervine tonic — a herb that nourishes and calms the nervous system. One of the oldest documented Medhya Rasayanas, it appears in Charaka Samhita as a specific remedy for improving memory, intelligence, and speech. Its active compounds include flavonoids, alkaloids (shankhpushpine), glycosides, and coumarins.

The honest answer about Shankhpushpi's evidence base is that it is promising but unproven in humans. As the Alzheimer's Drug Discovery Foundation's Cognitive Vitality programme notes, preclinical studies show that Shankhpushpi treatment improves memory, reduces biological markers of Alzheimer's disease, and decreases oxidative stress — but no randomised controlled clinical trials have tested whether it improves cognitive function or prevents age-related cognitive decline in humans.

What the existing human data shows:

An open-label clinical study of 102 young healthy volunteers compared Shankhpushpi supplementation (500 mg tablets, twice daily after food with milk, for 2 months) with a yoga intervention. The Shankhpushpi group showed apparent improvements in long-term memory as measured by auditory delayed, visual delayed, auditory recognition, and visual recognition tests. There was no placebo control group, however, making it impossible to separate the herb's effect from the placebo response or natural learning effects.
A second open-label study of 90 school children used a combination of Ayurvedic herbs including Shankhpushpi and found improvements in short-term memory and serial recall. Because the treatment included multiple plant products, no benefit can be attributed specifically to Shankhpushpi.
No randomised, double-blind, placebo-controlled trials have been published for Shankhpushpi as of mid-2026.

The preclinical data is genuinely interesting. Animal studies show that Shankhpushpi extracts reduce acetylcholinesterase activity (the same mechanism as Brahmi), decrease amyloid-beta accumulation relevant to Alzheimer's pathology, and protect neurons from oxidative damage. These are plausible mechanisms for cognitive benefit, but animal models frequently fail to translate to human outcomes.

Safety profile: Shankhpushpi is generally considered safe at recommended doses and has been used in Ayurvedic practice for centuries. Two specific interactions warrant attention, though. First, it has a mild blood pressure-lowering effect, so people with hypotension or those on antihypertensive medications should use it cautiously. Second — and more clinically significant — Shankhpushpi can decrease blood concentrations of phenytoin, an anti-seizure medication, reducing seizure control. Anyone on antiepileptic drugs must consult a neurologist before taking Shankhpushpi.

How do these herbs work mechanistically — and why does that matter for buyers?

Understanding the mechanisms helps you match the herb to your specific cognitive concern rather than treating all three as interchangeable "brain boosters."

Brahmi's primary mechanisms are cholinergic enhancement (increasing acetylcholine availability), antioxidant protection of neuronal membranes, and modulation of serotonin pathways. This makes it most relevant for memory consolidation — the process by which short-term memories become long-term ones. If your primary complaint is forgetting things you recently learned, Brahmi has the most direct mechanistic and clinical support.

Ashwagandha's primary mechanisms are HPA axis modulation (reducing cortisol), GABAergic activity (calming the nervous system), and antioxidant neuroprotection via withanolides. This makes it most relevant for stress-induced cognitive impairment — the kind of brain fog, poor concentration, and forgetfulness that accompanies chronic work stress, burnout, or anxiety. If your cognitive complaints are worst during high-stress periods and improve on holidays, Ashwagandha is the more targeted choice.

Shankhpushpi's proposed mechanisms include acetylcholinesterase inhibition, GABA receptor modulation, and antioxidant activity via flavonoids. In theory, it should work similarly to Brahmi on memory and similarly to Ashwagandha on anxiety. In practice, the human evidence to confirm these mechanisms is absent.

The Ayurvedic framework, as explained by experts quoted in Hindustan Times, views these herbs not as isolated pharmacological agents but as part of a system that includes diet (Ahara), lifestyle (Vihara), and mental practices. Modern research is beginning to validate this systems approach — several studies show that Brahmi and Ashwagandha produce stronger cognitive effects when combined with adequate sleep and stress management than when used in isolation.

Which herb is better for which type of person?

This is the question most buyers actually need answered, and the honest answer is that it depends on the root cause of your cognitive concern.

For students and professionals wanting to improve learning and memory retention: Brahmi has the strongest and most direct evidence. The 8–12 week timeline means it is not a quick fix before an exam, but a sustained course started well in advance of a demanding period. Look for a standardised extract with at least 20% bacosides, not raw powder. Doses used in positive RCTs range from 300–450 mg/day.

For people experiencing stress-related brain fog, poor concentration, or burnout: Ashwagandha is the better-evidenced choice. Its cortisol-lowering effects are among the most consistently replicated findings in the Ayurvedic supplement literature. A standardised root extract (KSM-66 or Sensoril are the most studied branded extracts) at 300–600 mg/day is the evidence-supported range.

For older adults concerned about age-related cognitive decline: Both Brahmi and Ashwagandha have shown benefits in older adult populations in RCTs. Brahmi's cholinergic effects are particularly relevant given that age-related memory decline is partly driven by reduced acetylcholine signalling. Ashwagandha's neuroprotective and anti-inflammatory effects are also relevant to the neuroinflammation that accompanies ageing.

For those drawn to Shankhpushpi by tradition or combination products: The herb is unlikely to cause harm at standard doses and may offer benefits — the preclinical data is genuinely promising. But buyers should understand they are acting on traditional use and animal data, not human RCT evidence. If a product combines Shankhpushpi with Brahmi or Ashwagandha, the cognitive benefit is more likely attributable to the latter two.

A note on combination products: many Indian market formulations combine all three herbs (plus others like Jatamansi, Vacha, or Guduchi) into a single syrup or tablet. These combinations are deeply rooted in classical Ayurvedic formulation principles, which hold that herbs often work synergistically. Combination products make it nearly impossible to attribute any observed benefit to a specific ingredient, however, and they complicate dosing because each herb may be present at sub-therapeutic levels.

What should you look for on a product label in India?

The Indian supplement market for these herbs is large and variable in quality. Several practical considerations apply:

Standardisation: For Brahmi, look for products specifying bacoside content (minimum 20%, ideally 40–55%). For Ashwagandha, look for withanolide content (minimum 2.5–5%) or a named branded extract like KSM-66 or Sensoril, which have been used in published clinical trials. Shankhpushpi products are rarely standardised to a specific marker compound, which is itself a reflection of the less developed research base.

Form: Extracts are generally more potent and consistent than raw powders. A 300 mg extract standardised to 40% bacosides delivers a very different dose of active compounds than 300 mg of raw Brahmi powder.

AYUSH licensing: In India, Ayurvedic supplements are regulated by the Ministry of AYUSH. Products should carry a valid AYUSH license number. This does not guarantee efficacy but does indicate the product has met basic manufacturing standards.

Third-party testing: Few Indian brands publish third-party heavy metal or pesticide testing results for these herbs, despite the fact that Indian-grown medicinal herbs can accumulate heavy metals from soil. This is an area where the market has significant room to improve. Brands that publish Certificates of Analysis (CoAs) from independent labs deserve preference.

Combination vs. single-herb: If you want to understand what is working for you, start with a single-herb product. Combination syrups and tablets are traditional and may be effective, but they make it impossible to identify which herb is responsible for any benefit or side effect you experience.

Are there any risks or drug interactions buyers should know about?

All three herbs are generally well-tolerated at standard doses, but several interactions and contraindications deserve explicit mention.

Brahmi at high doses (above 450 mg/day of extract) commonly causes gastrointestinal side effects including nausea, increased bowel movements, and stomach cramps. Taking it with food reduces this risk. It may also potentiate the effects of sedative medications and thyroid drugs, though evidence for these interactions is limited.

Ashwagandha can stimulate thyroid hormone production and is therefore contraindicated in hyperthyroidism. Rare cases of drug-induced liver injury (DILI) have been reported, predominantly at high doses or with prolonged use beyond 6 months without breaks. It has mild sedative properties and may enhance the effects of benzodiazepines, sleep medications, and alcohol. Pregnant women should avoid it, as it has traditionally been used as an abortifacient at high doses.

Shankhpushpi's most clinically significant interaction is with phenytoin (Dilantin), an anti-seizure medication. Research reviewed by the Alzheimer's Drug Discovery Foundation confirms that Shankhpushpi can decrease phenytoin blood concentrations, leading to breakthrough seizures. This is a serious interaction that anyone on antiepileptic therapy must discuss with their neurologist. Its blood pressure-lowering effect is mild but relevant for people already on antihypertensive medications.

None of these herbs should be viewed as replacements for medical treatment of cognitive disorders including dementia, Alzheimer's disease, or ADHD. They are best understood as supportive tools for healthy adults seeking to maintain or modestly improve cognitive function.

What does the Ayurvedic framework add that modern pharmacology misses?

This is worth addressing directly, because the Ayurvedic tradition around these herbs is not simply a collection of unvalidated folk claims. Several aspects of the classical framework have proven prescient when examined through a modern lens.

The concept of Dhi, Dhriti, and Smriti — acquisition, retention, and recall — maps remarkably well onto modern cognitive neuroscience's distinction between encoding, consolidation, and retrieval. Ayurvedic texts prescribed different herbs for different deficits in this triad, which is consistent with the finding that Brahmi appears to have its strongest effects on consolidation (Dhriti) while Ashwagandha's stress-reduction effects primarily support encoding (Dhi) in high-stress individuals.

The Rasayana concept — that these herbs work best as sustained courses rather than acute doses — is validated by the clinical data. No study has shown meaningful cognitive benefits from a single dose of Brahmi or Ashwagandha. The benefits accumulate over weeks, consistent with the neuroplasticity mechanisms proposed: synaptic remodelling, neurogenesis in the hippocampus, reduction of chronic neuroinflammation.

The Ayurvedic insistence on lifestyle context is also supported by modern research. Cymbiotika's health hub notes that Ayurvedic cognitive support is built on a foundation of Ahara (diet) and Vihara (lifestyle), with herbs as an adjunct rather than the primary intervention. This is consistent with the evidence that sleep deprivation, chronic stress, and poor diet each independently impair memory in ways that no supplement can fully compensate for.

Where the Ayurvedic framework is less reliable is in its assumption that traditional use automatically validates efficacy. Shankhpushpi's millennia of use as a memory herb does not substitute for randomised controlled trials, and the history of medicine is full of long-used remedies that failed to outperform placebo when rigorously tested. The honest position is that traditional use raises the prior probability that a herb is worth investigating — it does not confirm that it works.

How should you practically approach using these herbs?

A sensible protocol for someone wanting to explore these herbs for cognitive support:

Start with a clear goal. Are you trying to improve memory and learning? Brahmi is the evidence-based first choice. Are you managing stress-related brain fog? Ashwagandha is more targeted. Are you drawn to Shankhpushpi by tradition or because it is in a combination product you already use? Proceed with realistic expectations about the evidence.

Give it enough time. The minimum meaningful trial period for any of these herbs is 8 weeks of consistent daily use. Expecting results in a week is inconsistent with both the clinical evidence and the Ayurvedic framework.

Address the foundations first. No herb compensates for chronic sleep deprivation, which is the single largest modifiable driver of memory impairment in working-age adults. The stress-reduction benefits of Ashwagandha are most relevant when combined with actual stress management practices — not as a substitute for them.

Consult a physician if you are on medications. The phenytoin interaction with Shankhpushpi is serious. The thyroid interaction with Ashwagandha is clinically relevant. Anyone on prescription medications should discuss these herbs with their doctor before starting.

Track your response. Keep a simple log of your cognitive complaints before starting and reassess at 8 and 12 weeks. Cognitive self-assessment is notoriously unreliable, but structured tracking is better than vague impressions. Some people find validated tools like the Cognifit or Cambridge Brain Sciences assessments useful for this purpose.

For readers interested in the broader space of evidence-based supplements for brain and body health, our guides on Berberine for insulin resistance and Curcumin for joint health apply the same evidence-grading approach to other widely used Ayurvedic and natural compounds.

The bottom line: where does the evidence actually land?

The evidence for these three herbs is real but unequal, and understanding that inequality is the most useful thing a buyer can take away from this article.

Brahmi (Bacopa monnieri) is the best-evidenced cognitive herb in the Ayurvedic tradition. Multiple RCTs in healthy adults confirm meaningful improvements in memory consolidation and learning rate after 8–12 weeks of standardised extract use. The effect size is modest — this is not a dramatic cognitive enhancer — but it is reproducible and the safety profile is well-characterised.

Ashwagandha (Withania somnifera) has solid evidence for reducing stress-related cognitive impairment and improving reaction time and executive function. Its cognitive benefits are most pronounced in people whose mental performance is being degraded by chronic stress or poor sleep. The cortisol-lowering effect is among the most consistently replicated findings in the adaptogen literature.

Shankhpushpi (Convolvulus pluricaulis) has a rich traditional history and genuinely interesting preclinical data, but the absence of rigorous human RCTs means its cognitive claims cannot be verified with the same confidence as Brahmi or Ashwagandha. It is not without value — traditional use over centuries is not nothing — but buyers deserve to know they are working with a thinner evidence base.

All three herbs are best understood as slow-acting tonics within a broader lifestyle framework, not as quick cognitive fixes. The Ayurvedic tradition got that part right, and modern neuroscience has largely confirmed it.